Tag: anda

Zydus gets USFDA nod for generic version of anti-epilepsy drug

Zydus gets USFDA nod for generic version of anti-epilepsy drug

cpooldigitalLeave a Comment on Zydus gets USFDA nod for generic version of anti-epilepsy drug

Eligible for 180 days shared exclusivity for Brivaracetam tablets. Eligible for 180 days shared exclusivity for Brivaracetam tablets. Drugmaker Zydus Lifesciences has received the United States Food and Drug Administration (USFDA) approval to market Brivaracetam tablets.  An antiepileptic drug, the approved product is a generic of multinational pharma firm UCB’s Briviact. “U.S. subsidiary Zydus Pharmaceuticals […]

Continue Reading
Dr. Reddy’s to acquire Slayback’s eyedrop rights

Dr. Reddy’s to acquire Slayback’s eyedrop rights

cpooldigitalLeave a Comment on Dr. Reddy’s to acquire Slayback’s eyedrop rights

Pharma major Dr. Reddy’s Laboratories has entered into a licensing agreement to obtain rights to New Jersey-based Slayback Pharma’s Brimonidine Tartrate Ophthalmic Solution 0.025%. Slayback Pharma is the first to file an ANDA (abbreviated new drug application) for the private label equivalent for Lumify with the U.S. Food and Drug Administration (USFDA) under Paragraph IV […]

Continue Reading